Strategic Wealth Partners’s Oragenics OGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGEN
Strategic Wealth Partners's OGEN Position: Q3 2026 in Review
Strategic Wealth Partners held its Oragenics (OGEN) position steady in Q3 2026 at 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1353.
Strategic Wealth Partners first reported a position in OGEN in Q2 2025 and has held it in 6 quarters since. The position peaked at $4 in Q2 2025. 17 funds tracked by Wall St. Rank hold OGEN as of Q3 2026.
- Strategic Wealth Partners held 1 share of Oragenics worth $0 as of Q3 2026.
- Strategic Wealth Partners left its Oragenics share count unchanged in Q3 2026.
- Oragenics made up ﹤0.01% of Strategic Wealth Partners's portfolio in Q3 2026, its #1353 holding.
- Strategic Wealth Partners first reported a position in Oragenics in Q2 2025 and has held it in 6 quarters since.
- Strategic Wealth Partners's Oragenics position peaked at $4 in Q2 2025.
- 17 funds tracked by Wall St. Rank held Oragenics as of Q3 2026.
Based on Strategic Wealth Partners's 13F filing for Q3 2026, filed 13 Nov 2026.